US-based biopharma company Syndexa Pharmaceuticals secured $8.5m in series B1 funding from backers including MP Healthcare Venture Management (MPH), a venture capital firm which acts as a subsidiary of pharmaceutical concern Mitsubishi Tanabe Pharma Corporation and its parent company, Mitsubishi Chemical Holdings. Also participating in the B1 round was the founder of electronics hardware maker… Continue reading Syndexa finds a way to Mitsubishi cash
Author: Robert Lavine
NeuroTherapeutics avoids pain in funding
The biopharma company has taken its overall funding past the $60m mark, with participation from pharmaceutical corporations Pfizer, Novo and GlaxoSmithKline.
Dean boards Urban Airship
Ex-Skype CSO Christopher Dean joins the Salesforce and Verizon-backed marketing software company as its chief revenue officer.
MindSpeed accelerates growth with PicoChip purchase
PicoChip, a semiconductor technology firm backed by Intel, AT&T and Samsung, has been acquired by semiconductor corporation Mindspeed Technologies for more than $50m.
Rocket Lawyer reaches new heights
The online legal services company, backed by Google, Reed-Elsevier and Investor takes its series D round above $29m.
Compuware meets its Deadline Detroit
Local aggregated news startup Deadline Detroit has received seed funding from Compuware Ventures and is seeking out additional financing as it counts down to launch next month.
Google gets in quick for Nimble
Social CRM platform Nimble has raised $1m in seed funding with Google Ventures joining a raft of angels in backing the round.
McKelvey kits up for LockerDome
The sports-focused social network has appointed the co-founder of mobile payments company Square to its board a month after he participated in a $750,000 financing round.
Renewable Energy eyes $100m IPO
Corporate-backed biodiesel producer and supplier the Renewable Energy Group sets the range of its IPO, and looks to raise as much as $100m.
Lundbeck keeps its nerve with Ossianix
Neuroscience specialist H. Lundbeck has invested in Ossianix, developer of a treatment platform for problems linked to the central nervous system.
Priobiodrug compounds its funding with another $19m
Germany-based biopharmaceutical company Probiodrug secured €15m ($19.2m) in funding on Wednesday from investors including Biogen Idec New Ventures, a corporate venturing unit belonging to pharmaceutical corporation Biogen Idec, and biotechnology investment company BB Biotech. Also investing in the round were Edmond de Rothschild Investment Partners, which acts as a division of the Edmond de Rothschild… Continue reading Priobiodrug compounds its funding with another $19m
BGF makes an Unruly investment
The social video advertising platform, already profitable, has raised $25m which it will use to expand its activities internationally.
Abbott enters the world of NeuroGenetic
Abbott Biotech Ventures, one of the corporate venturing funds run by pharmaceutical corporation Abbott Laboratories, invested an undisclosed amount in US-based Alzheimer’s disease therapeutics company NeuroGenetic Pharmaceuticals (NGP) on Wednesday. Founded in 2009, NeuroGenetic’s technology is based around a compound, NGP555, that it claims can detect and reduce the brain plaques associated with Alzheimer’s. The… Continue reading Abbott enters the world of NeuroGenetic
Cargill looks for growth in AgriNurture
Agro-commercial business AgriNurture has raised $30m in funding from agribusiness conglomerate Cargill, which has taken a 28% stake.